SecBot SecBot

ITRM

Iterum Therapeutics plc
Nasdaq· Pharmaceutical Preparations· Inc. L2· CIK 0001659323 Biotech & Drug Discovery
—

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.145 → −$0.200 over 90 days.

The Street

last action Mar 2026
Recent actions
DateFirmActionRating
Mar 30, 2026HC Wainwright & Co.
DOWNGRADE
DOWNGRADENeutral
Aug 15, 2024HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Jun 21, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy
May 31, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy
May 14, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy
Apr 30, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy

Earnings setup

Estimates
−$0.20
EPS estimate, this quarter
−38%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Next Q———$0.00
Next FY-$0.24-$0.24–-$0.24+22.6%$10.0M
Current FY-$0.73-$0.73–-$0.73-10.6%$800.0K
Current Q-$0.20-$0.20–-$0.20-37.9%$410.0K
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
May 13, 2026 Earnings calendar
ITRM Q1 2026 Earnings Scheduled — 2026-05-13
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
May 13, 2026
Earnings date
ITRM Q1 2026 Earnings Scheduled — 2026-05-13
May 11, 2026
Earnings date
ITRM Q1 2026 Earnings Scheduled — 2026-05-11
Apr 29, 2026
Earnings date
ITRM Q4 2025 Earnings After Market Close — 2026-04-29
Mar 27, 2026
Press release
Iterum Therapeutics Announces Filing of Winding Up Petition
DUBLIN and CHICAGO, March 27, 2026 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (in Provisional Liquidation) (Nasdaq: ITRM) (the “Company” or…
Mar 12, 2026
Earnings date
ITRM Q4 2025 Earnings After Market Close — 2026-03-12